Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.

Bibliographic Details
Title:	Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Authors:	Kang, Yoon-Koo, Kim, Hyung-Don, Yook, Jeong Hwan, Park, Young-Kyu, Lee, Jong Seok, Kim, Young-Woo, Kim, Jin Young, Ryu, Min-Hee, Rha, Sun Young, Chung, Ik Joo, Kim, In-Ho, Oh, Sang Cheul, Park, Young Soo, Cheong, Jae-Ho, Jeong, Oh, Heo, Mi Hwa, Kim, Hark Kyun, Park, ChoHyun, Yoo, Chang Hak, Kang, Seok Yun
Source:	Journal of Clinical Oncology; 9/1/2024, Vol. 42 Issue 25, p2961-2965, 8p
Database:	Supplemental Index

More Details
ISSN:	0732183X
DOI:	10.1200/JCO.23.02167
Published in:	Journal of Clinical Oncology
Language:	English